Breaking News Instant updates and real-time market news.

NTR

Nutrien

, MOS

Mosaic

09:22
02/07/18
02/07
09:22
02/07/18
09:22

Nutrien 'strong' potash results positive for Mosaic, says Bernstein

Bernstein analyst Jonas Oxgaard notes that Nutrien (NTR) reported a "messy quarter" but announced "strong" potash results. The analyst believes the read-across to Mosaic (MOS) should be positive and continues to expect a beat by the latter when it reports quarterly results. Oxgaard reiterates an Outperform rating and $68 price target on Nutrien's shares.

NTR

Nutrien

MOS

Mosaic

  • 20

    Feb

NTR Nutrien

01/16/18
GSCO
01/16/18
INITIATION
Target $54
GSCO
Neutral
Nutrien initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Adam Samuelson started Nutrien with a Neutral rating and $54 price target. The analyst has concerns over potash industry overcapacity and sees downside risk to prices from current levels.
01/16/18
01/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Axalta Coating (AXTA) resumed with an Underperform at BofA/Merrill. 2. UBS (UBS) and Credit Suisse (CS) were initiated with an Underweight at Barclays. 3. Nutrien (NTR) initiated with a Neutral at Goldman Sachs. 4. Cambrex (CBM) initiated with an Outperform at William Blair. 5. Dicerna (DRNA) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/18
SBSH
01/23/18
UPGRADE
Target $61
SBSH
Buy
Nutrien upgraded to Buy from Neutral at Citi
Citi analyst P.J. Juvekar upgraded Nutrien to Buy and raised his price target for the shares to $61 from $20. Following the merger of of Potash Corp. and Agrium, the analyst sees cash deployment optionality as Nutrien divests stakes worth $4.5B with the potential to buyback 5% of its outstanding shares within 12-24 months. He also sees a "major opportunity" to cut costs through its $500M synergy goal. Juvekar believes "favorable trends" more than offset his ongoing cautious stance on potash fundamentals.
01/26/18
MSCO
01/26/18
INITIATION
Target $55
MSCO
Equal Weight
Nutrien resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Vincent Andrews resumed coverage of Nutrien with an Equal Weight rating and $55 price target, saying he expects the stock to be attractive to investors in a shrinking pool of Ag equity plays but he also believes fertilizer valuations already imply a substantial cyclical recovery.
MOS Mosaic

01/12/18
RBCM
01/12/18
NO CHANGE
Target $28
RBCM
Sector Perform
Mosaic price target raised to $28 from $24 at RBC Capital
RBC Capital analyst Andrew Wong raised his price target on Mosaic to $28, saying the company's prospects are gradually improving while also anticipating benefits from better execution and favorable P&K market conditions. Wong keeps his Sector Perform rating on Mosaic, noting the company has done well in highlighting the positives of its Vale Fertilizantes deal.
01/12/18
01/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mosaic (MOS) reinstated with a Neutral at JPMorgan. 2. Vantiv (VNTV) initiated with an Overweight at Stephens. 3. Copa Holdings (CPA) initiated with a Buy at BofA/Merrill. 4. Edison International (EIX) was initiated with a Neutral and Consolidated Edison (ED) was initiated with an Underweight at JPMorgan. 5. New Relic (NEWR) initiated with a Market Perform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/18
BERN
01/23/18
NO CHANGE
Target $44
BERN
Outperform
Mosaic price target raised to $44 from $33 at Bernstein
Bernstein analyst Jonas Oxgaard raised his price target for Mosaic to $44 from $33 saying it is his top pick for 2018 and that he believes shares are "significantly undervalued." The analyst reiterates an Outperform rating on the shares.
02/02/18
SPHN
02/02/18
INITIATION
Target $37
SPHN
Overweight
Mosaic initiated with an Overweight at Stephens
Stephens analsyt Mark Connelly initiated Mosaic with an Overweight and $37 price target. The analyst believes Mosaic has emerged as the industry's most credible capital allocator in a period of industry-induced excess capacity. CEO James O' Rourke's decision to acquire the Vale assets addresses the global competitive challenge from MENA producers, and comes while Brazil and phosphate markets are severely depressed, exactly when they should be bought, Connelly contends. Connelly believes Mosaic is positioned to have the biggest rebound among major ag input producers.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

11:17
02/23/18
02/23
11:17
02/23/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$10.12

0.06 (0.60%)

, RGR

Sturm, Ruger

$47.30

-1.7 (-3.47%)

11:16
02/23/18
02/23
11:16
02/23/18
11:16
Hot Stocks
Gun stocks fall as corporate pressure mounts on NRA »

The National Rifle…

AOBC

American Outdoor Brands

$10.12

0.06 (0.60%)

RGR

Sturm, Ruger

$47.30

-1.7 (-3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

$NYE

NYSE Market Internals

11:16
02/23/18
02/23
11:16
02/23/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$68.93

0.47 (0.69%)

11:12
02/23/18
02/23
11:12
02/23/18
11:12
Conference/Events
Xilinx management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HMHC

Houghton Mifflin

$7.65

0.1 (1.32%)

11:10
02/23/18
02/23
11:10
02/23/18
11:10
Options
Hefty option block in Houghton Mifflin Harcourt as shares falter »

Hefty option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRA

Kraton

$45.31

1.6 (3.66%)

11:10
02/23/18
02/23
11:10
02/23/18
11:10
Conference/Events
Kraton management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SBUX

Starbucks

$55.40

-0.7 (-1.25%)

11:00
02/23/18
02/23
11:00
02/23/18
11:00
Options
Starbucks puts active at the opening bell Friday »

Starbucks puts active at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 21

    Mar

PSO

Pearson

$9.66

-0.08 (-0.82%)

10:50
02/23/18
02/23
10:50
02/23/18
10:50
Hot Stocks
Pearson sees FY18 adjusted ops profit GBP520M-GBP560M »

The base for 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$96.83

-0.06 (-0.06%)

10:50
02/23/18
02/23
10:50
02/23/18
10:50
Options
25K Lowes Mar - Oct 95 call spreads bought for $5.75 »

25K Lowes Mar - Oct 95…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

PSO

Pearson

$9.66

-0.08 (-0.82%)

10:48
02/23/18
02/23
10:48
02/23/18
10:48
Earnings
Pearson reports preliminary FY17 adjusted operating profit GBP576M, down 9% »

Reports preliminary FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$39.04

0.8299 (2.17%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:45
02/23/18
02/23
10:45
02/23/18
10:45
General news
Boston Fed hawk Rosengren: low real rates are likely for some time »

Boston Fed hawk…

MDT

Medtronic

$80.51

0.1 (0.12%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Conference/Events
Medtronic has a conference call hosted by JPMorgan »

JPMorgan Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 14

    Mar

  • 23

    Mar

TTMI

TTM Technologies

$15.52

-0.07 (-0.45%)

10:45
02/23/18
02/23
10:45
02/23/18
10:45
Conference/Events
TTM Technologies has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

VLKAY

Volkswagen

$40.89

0.46 (1.14%)

10:41
02/23/18
02/23
10:41
02/23/18
10:41
Earnings
Volkswagen sees fiscal 2018 sales up as much as 5% »

Volkswagen said in its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$38.15

-0.2 (-0.52%)

, FOXA

21st Century Fox

$37.16

0.1 (0.27%)

10:39
02/23/18
02/23
10:39
02/23/18
10:39
Hot Stocks
Box Office Battle: 'Black Panther' expecting $120M second weekend »

Marvel and Disney's…

VIA

Viacom

$38.15

-0.2 (-0.52%)

FOXA

21st Century Fox

$37.16

0.1 (0.27%)

LGF.B

Lionsgate

$26.79

0.01 (0.04%)

VIAB

Viacom

$32.93

-0.1 (-0.30%)

CMCSA

Comcast

$38.80

-0.21 (-0.54%)

CMCSK

Comcast

LGF.A

Lionsgate

$28.02

0.05 (0.18%)

TWX

Time Warner

$94.17

-0.2 (-0.21%)

DIS

Disney

$105.53

0.29 (0.28%)

SNE

Sony

$49.64

-0.21 (-0.42%)

FOX

21st Century Fox

$36.73

0.17 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 20

    Mar

  • 23

    Apr

10:35
02/23/18
02/23
10:35
02/23/18
10:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD slid…

ATI

Allegheny Technologies

$27.04

0.41 (1.54%)

10:33
02/23/18
02/23
10:33
02/23/18
10:33
Conference/Events
Allegheny Technologies management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 01

    May

  • 02

    May

  • 03

    May

NVRO

Nevro

$81.92

2.27 (2.85%)

10:31
02/23/18
02/23
10:31
02/23/18
10:31
Recommendations
Nevro analyst commentary  »

Nevro setup favorable,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
02/23/18
02/23
10:30
02/23/18
10:30
General news
Treasury Option Action: put buying in the belly »

Treasury Option Action:…

10:27
02/23/18
02/23
10:27
02/23/18
10:27
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts provide a…

MDXG

MiMedx

$8.88

-0.17 (-1.88%)

10:25
02/23/18
02/23
10:25
02/23/18
10:25
Conference/Events
MiMedx to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 14

    Mar

10:24
02/23/18
02/23
10:24
02/23/18
10:24
General news
Averages up in early trading but off best levels »

Stock futures moved…

WRK

WestRock

$65.72

0.44 (0.67%)

10:21
02/23/18
02/23
10:21
02/23/18
10:21
Conference/Events
WestRock management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GILD

Gilead

$79.40

-1.29 (-1.60%)

, GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

10:20
02/23/18
02/23
10:20
02/23/18
10:20
Conference/Events
Leerink pharmaceuticals analysts to hold an analyst/industry conference call »

Analyst Research Team…

GILD

Gilead

$79.40

-1.29 (-1.60%)

GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 25

    Mar

  • 23

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.